![]() To measure the reputation of a company, Caliber uses a Trust & Like Score as a measurement of corporate reputation. To understand how the pandemic has impacted the reputation of the industry, European Pharmaceutical Review’s Hannah Balfour discussed the findings of Caliber’s Global Pharma Study 2020 with the company’s Chief Executive Officer, Shahar Silbershatz. The report was released before COVID-19, which thrusted pharma R&D into the spotlight. The criticisms in the report focused on high drug costs and the industry’s role in the US opioid crisis, suggesting that pharma’s rating is unlikely to recover “until its role in the opioid epidemic is addressed and the political pressure on the industry for high prices and massive profits subsides”. The researchers reported that pharma had the lowest reputation score since the US analytical company Gallup began polling public opinion of industries in 2001. ![]() ![]() This negative public perception was highlighted in a report published in September 2019, which found that pharma had the worst reputation of all industries according to the American public. ![]() The pharmaceutical industry, and in particular big pharma, has been hampered with reputational issues for years. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |